JENNIFER LUNDGREN: Open Payments
NPI 1104515311 · SHENANDOAH, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$172 in 9 payments from 8 companies in 2025. Trend: 2023 $16 · 2024 $55 · 2025 $172
Food & beverage: $172
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $24 |
| Lilly USA, LLC | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
| ACADIA Pharmaceuticals Inc | 1 | $17 |
| Alkermes, Inc. | 1 | $17 |
Products named: Qelbree, TRINTELLIX, REXULTI, ZEPBOUND, SPRAVATO, INGREZZA, NUPLAZID, ARISTADA.
Industry payments across IA — which companies pay providers there.
